Page last updated: 2024-08-17

medroxyprogesterone acetate and Cardiac Diseases

medroxyprogesterone acetate has been researched along with Cardiac Diseases in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	5 (50.00)	29.6817
2010's	1 (10.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haapalahti, P; Lantto, H; Mikkola, TS; Sovijärvi, ARA; Väänänen, H; Viitasalo, M; Ylikorkala, O	1
Assaf, AR; Black, HR; Crouse, JR; Cushman, M; Detrano, R; Heckbert, SR; Hsia, J; Johnson, KC; Lasser, NL; Manson, JE; Rossouw, JE; Stein, E; Strickland, OL; Trevisan, M; Wong, ND	1
Beckman, M	1
Gousse, A; Rivera, R	1
Healy, B	1
Astedt, B; Lecander, I; Lindoff, C; Martinsson, G; Peterson, F	1
Evans, MF; Gerstein, F	1
Kamp, O; Kenemans, P; Mijatovic, V; Neele, SJ; Netelenbos, JC; Pines, A; van der Mooren, MJ; Vogelvang, TE	1

Trials

7 trial(s) available for medroxyprogesterone acetate and Cardiac Diseases

Article	Year
Vasomotor hot flashes and cardiac repolarization: a randomized placebo-controlled trial of postmenopausal hormone therapy. Menopause (New York, N.Y.), 2017, Volume: 24, Issue:12 Topics: Arrhythmias, Cardiac; Double-Blind Method; Electrocardiography; Estradiol; Estrogen Replacement Therapy; Female; Heart; Heart Diseases; Heart Rate; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause	2017
Hormone replacement therapy. The Medical letter on drugs and therapeutics, 2002, Sep-02, Volume: 44, Issue:1138 Topics: Aged; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Heart Diseases; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause	2002
Estrogen plus progestin and the risk of coronary heart disease. The New England journal of medicine, 2003, Aug-07, Volume: 349, Issue:6 Topics: Aged; Case-Control Studies; Coronary Disease; Double-Blind Method; Drug Combinations; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Heart Diseases; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Risk Factors; Treatment Outcome	2003
Does postmenopausal hormone therapy cause urinary incontinence? Nature clinical practice. Urology, 2006, Volume: 3, Issue:6 Topics: Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Heart Diseases; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Retrospective Studies; Risk Factors; Urinary Incontinence; Urodynamics	2006
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA, 1995, Jan-18, Volume: 273, Issue:3 Topics: Aged; Cholesterol, HDL; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Glucose; Heart Diseases; Humans; Insulin; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Systole; Weight Gain	1995
Hormone replacement therapy. Does it actually help with heart disease? Canadian family physician Medecin de famille canadien, 1999, Volume: 45 Topics: Adult; Aged; Contraceptive Agents, Female; Double-Blind Method; Estrogens; Female; Follow-Up Studies; Heart Diseases; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Preventive Medicine; Risk Factors	1999
Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in healthy postmenopausal women: two randomized, placebo-controlled, 2-year studies. American journal of obstetrics and gynecology, 2002, Volume: 186, Issue:4 Topics: Double-Blind Method; Echocardiography; Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Heart Diseases; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Raloxifene Hydrochloride; Systole; Ventricular Function, Left	2002

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Cardiac Diseases

Article	Year
Wayward sisters. Progestin siblings exert opposite effects on monkey hearts. Science of aging knowledge environment : SAGE KE, 2004, Oct-13, Volume: 2004, Issue:41 Topics: Animals; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Haplorhini; Heart; Heart Diseases; Humans; Medroxyprogesterone Acetate; Norethindrone; Progestins	2004
PEPI in perspective. Good answers spawn pressing questions. JAMA, 1995, Jan-18, Volume: 273, Issue:3 Topics: Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Heart Diseases; Humans; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic	1995
Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease. Maturitas, 1996, Volume: 24, Issue:1-2 Topics: Administration, Cutaneous; Administration, Oral; Adult; Antithrombin III; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Heart Diseases; Hemostasis; Humans; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Postmenopause; Progesterone Congeners; Prospective Studies; Protein C; Regression Analysis; Risk Factors; Serine Proteinase Inhibitors; Tissue Plasminogen Activator	1996